Carbazole-containing arylcarboxamides as BACE1 inhibitors

被引:26
作者
Bertini, Simone [1 ]
Asso, Valentina [1 ]
Ghilardi, Elisa [1 ]
Granchi, Carlotta [1 ]
Manera, Clementina [1 ]
Minutolo, Filippo [1 ]
Saccomanni, Giuseppe [1 ]
Bortolato, Andrea [2 ]
Mason, Jonathan [2 ,4 ]
Moro, Stefano [3 ]
Macchia, Marco [1 ]
机构
[1] Univ Pisa, Dipartimento Sci Farmaceut, I-56126 Pisa, Italy
[2] Heptares Therapeut Ltd, Welwyn Garden City AL7 RAX, Herts, England
[3] Univ Padua, Dipartimento Sci Farmaceut, Mol Modeling Sect, I-35131 Padua, Italy
[4] Lundbeck AS, DK-2500 Copenhagen, Denmark
关键词
Alzheimer; BACE1; Carbazole; Molecular docking; Flap; AMYLOID PRECURSOR PROTEIN; BETA-SECRETASE; ALZHEIMERS-DISEASE; CRYSTAL-STRUCTURE; DESIGN; MODEL; SITE; MATURATION; PREDICTION; DOCKING;
D O I
10.1016/j.bmcl.2011.09.064
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
beta-Secretase (BACE1) is widely recognized as a prime drug target for the treatment of Alzheimer's disease (AD). In this Letter, we report the synthesis and the BACE1 inhibitory activity of novel, variously substituted N-[3-(9H-carbazol-9-yl)-2-hydroxypropyl]-arylcarboxamides. The best results have been obtained with the introduction of a 4-OMe substituent (IC50 = 3.8 mu M) or a 3,4-dichloro substituent (IC50 = 2.5 mu M) in the amidic aromatic ring. The blood-brain barrier penetration predictions resulted to be promising for this type of compounds. To better understand the structure-activity relationships (SAR) of the new derivatives, a docking study procedure has been applied exploiting different conformational and ionic states of BACE1. (C) 2011 Elsevier Ltd. All rights reserved.
引用
收藏
页码:6657 / 6661
页数:5
相关论文
共 29 条
[1]   α-Naphthylaminopropan-2-ol Derivatives as BACE1 Inhibitors [J].
Asso, Valentina ;
Ghilardi, Elisa ;
Bertini, Simone ;
Digiacomo, Maria ;
Granchi, Carlotta ;
Minutolo, Filippo ;
Rapposelli, Simona ;
Bortolato, Andrea ;
Moro, Stefano ;
Macchia, Marco .
CHEMMEDCHEM, 2008, 3 (10) :1530-1534
[2]   Tau-mediated neurodegeneration in Alzheimer's disease and related disorders [J].
Ballatore, Carlo ;
Lee, Virginia M. -Y. ;
Trojanowski, John Q. .
NATURE REVIEWS NEUROSCIENCE, 2007, 8 (09) :663-672
[3]   Design and synthesis of 2,3,5-substituted imidazolidin-4-one inhibitors of BACE-1 [J].
Barrow, James C. ;
Rittle, Kenneth E. ;
Ngo, Phung L. ;
Selnick, Harold G. ;
Graham, Samuel L. ;
Pitzenberger, Steven M. ;
McGaughey, Georgia B. ;
Colussi, Dennis ;
Lai, Ming-Tain ;
Huang, Qian ;
Tugusheva, Katherine ;
Espeseth, Amy S. ;
Simon, Adam J. ;
Munshi, Sanjeev K. ;
Vacca, Joseph P. .
CHEMMEDCHEM, 2007, 2 (07) :995-999
[4]   The Protein Data Bank [J].
Berman, HM ;
Westbrook, J ;
Feng, Z ;
Gilliland, G ;
Bhat, TN ;
Weissig, H ;
Shindyalov, IN ;
Bourne, PE .
NUCLEIC ACIDS RESEARCH, 2000, 28 (01) :235-242
[5]   BACE1 inhibitory activities of enantiomerically pure, variously substituted N-(3-(4-benzhydrylpiperazin-1-yl)-2-hydroxypropyl) arylsulfonamides [J].
Bertini, Simone ;
Ghilardi, Elisa ;
Asso, Valentina ;
Granchi, Carlotta ;
Minutolo, Filippo ;
Pineschi, Mauro ;
Di Bussolo, Valeria ;
Bortolato, Andrea ;
Moro, Stefano ;
Saba, Alessandro ;
Macchia, Marco .
BIOORGANIC & MEDICINAL CHEMISTRY, 2010, 18 (22) :7991-7996
[6]   Maturation and pro-peptide cleavage of β-secretase [J].
Capell, A ;
Steiner, H ;
Willem, M ;
Kaiser, H ;
Meyer, C ;
Walter, J ;
Lammich, S ;
Multhaup, G ;
Haass, C .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (40) :30849-30854
[7]   Evaluation of the symmetric model for myosin-linked regulation: effect of site-directed mutations in the regulatory light chain on scallop myosin [J].
Colegrave, M ;
Patel, H ;
Offer, G ;
Chantler, PD .
BIOCHEMICAL JOURNAL, 2003, 374 :89-96
[8]   The secretases: enzymes with therapeutic potential in Alzheimer disease [J].
De Strooper, Bart ;
Vassar, Robert ;
Golde, Todd .
NATURE REVIEWS NEUROLOGY, 2010, 6 (02) :99-107
[9]   Aspartic proteases in drug discovery [J].
Eder, Joerg ;
Hommel, Ulrich ;
Cumin, Frederic ;
Martoglio, Bruno ;
Gerhartz, Bernd .
CURRENT PHARMACEUTICAL DESIGN, 2007, 13 (03) :271-285
[10]   Glide: A new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy [J].
Friesner, RA ;
Banks, JL ;
Murphy, RB ;
Halgren, TA ;
Klicic, JJ ;
Mainz, DT ;
Repasky, MP ;
Knoll, EH ;
Shelley, M ;
Perry, JK ;
Shaw, DE ;
Francis, P ;
Shenkin, PS .
JOURNAL OF MEDICINAL CHEMISTRY, 2004, 47 (07) :1739-1749